Justin C Moser MD
Melanoma
Associate Clinical Investigator, HonorHealth Research and Innovation Institute Clinical Assistant Professor, University of Arizona College of Medicine - Phoenix Adjunct Faculty, Translational Genomic Research Institute (TGen)
Join to View Full Profile
10510 N 92nd StSte 200Scottsdale, AZ 85258
Phone+1 480-323-4638
Dr. Moser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Melanoma and Phase 1 specialist, with special focus on immunotherapeutics and uveal melanoma
Education & Training
University of Utah HealthFellowship, Hematology and Medical Oncology, 2016 - 2019
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2013 - 2016
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2013
Certifications & Licensure
AZ State Medical License 2019 - 2026
UT State Medical License 2016 - 2020
MN State Medical License 2014 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Innovation Award The Arizona Clinical Oncology Society, 2021
- Visiting Fellow, Cancer Therapy Evaluation Program National Cancer Institute, 2017
- National ACP Doctors Dilemma Semi-Finalist Team Member 2016
- Join now to see all
Publications & Presentations
PubMed
- Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.Erin McGillivray, Karam Ashouri, Eftychia Chatziioannou, Jesús Antonio Ocejo Gallegos, Jabra Zarka
The British Journal of Dermatology. 2025-01-24 - 1 citationsBasal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer.Abbie S Ireland, Sarah B Hawgood, Daniel A Xie, Margaret W Barbier, Scarlett Lucas-Randolph
Biorxiv. 2024-11-15 - 17 citationsBotensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial.Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Joseph E Grossman
Nature Medicine. 2024-09-01
Press Mentions
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical TrialsJanuary 8th, 2025- New HonorHealth Treatment Aims to Eliminate Melanoma with a Single BlowMay 2nd, 2024
- ‘COVID Saved My Life:’ Phoenix Mom Says Virus Helped Reveal Cancerous TumorsAugust 8th, 2024
Grant Support
- Travel Grant Award RecipientDepartment of Experiemental Therapuetics, Huntsman Cancer Institute2017–Present
- Medical Oncology Small GrantMayo Clinic2015–Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
